The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
September 13, 2024 06:00 ET
|
The Ensign Group, Inc.
SAN JUAN CAPISTRANO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled...
Ragnarok X: Next Generation Official Launching in China on September 13, 2024
September 13, 2024 06:00 ET
|
GRAVITY Co., Ltd.
Seoul, Sept. 13, 2024 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd (NASDAQGM: GRVY) (‘Gravity’ or ‘Company’), a developer and publisher of online and mobile games, announced the official launch of ‘Ragnarok...
Announcement Potential Entering of Distribution Agreement with CICC and JPMorgan
September 13, 2024 05:28 ET
|
Garden stage Limited
Hong Kong, Sept. 13, 2024 (GLOBE NEWSWIRE) -- I Win Securities Limited (“I Win”), a wholly-owned subsidiaries of Garden Stage Limited (NASDAQ: GSIW) (“Garden Stage”), has been in advanced...
Cooperation Agreement with ZZC
September 13, 2024 05:27 ET
|
Garden stage Limited
Hong Kong, Sept. 13, 2024 (GLOBE NEWSWIRE) -- I Win Securities Limited and I Win Asset Management Limited (“I Win”), both being wholly-owned subsidiaries of Garden Stage Limited (NASDAQ: GSIW)...
Moody’s upgrades our rating to investment grade
September 13, 2024 03:05 ET
|
JSC Kaspi.kz
ALMATY, Kazakhstan, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Moody’s has upgraded its long-term deposit ratings to investment grade Baa3 from Ba1 with a stable outlook for Kaspi Bank, a core part of...
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
September 12, 2024 22:37 ET
|
Zenas BioPharma
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
September 12, 2024 22:34 ET
|
Centessa Pharmaceuticals plc
BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are...
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
September 12, 2024 21:15 ET
|
Bicara Therapeutics Inc.
BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...
MBX Biosciences Announces Pricing of Initial Public Offering
September 12, 2024 19:11 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 12, 2024 19:00 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...